| Literature DB >> 35017833 |
Theeb Al-Marri1, Abdulla Al-Marri2, Reham Al-Zanbaqi3, Ahmad Al Ajmi4, Mahmoud Fayez1,5.
Abstract
BACKGROUND AND AIM: Backyard chicken flocks have traditionally been regarded as an essential food source in developed countries; however, they may act as reservoirs and spread various zoonotic bacterial pathogens. This study was designed to investigate the prevalence, phenotypic resistance, biofilm formation (BF), and pathotypes of Escherichia coli isolates from backyard poultry farms.Entities:
Keywords: Escherichia coli; backyard broilers; multidrug resistance; virulence genes
Year: 2021 PMID: 35017833 PMCID: PMC8743762 DOI: 10.14202/vetworld.2021.2869-2877
Source DB: PubMed Journal: Vet World ISSN: 0972-8988
Primers, probes, and melting temperature used in amplification of different virulence genes.
| Primers | Target | Oligonucleotide sequence (5×à 3’) | Melting temperature | Amplicon (bp) | Reference |
|---|---|---|---|---|---|
| iss-F | Increases serum survival gene | CGGGAATTGGACAAGAGAAAAC | 60 | 57 | [ |
| iss-R | TTTCTGCACCGCCACAAA | ||||
| FAM | TTTGGCTGCATCAAC | ||||
| iutA-F | Ferric aerobactin receptor gene | CGGTGGCGTACGCTATCAGT | 60 | 59 | |
| iutA-R | GCGCGTAGCCGATGAAAT | ||||
| VIC | CACTGAAAACAAGATTGAT | ||||
| hlyF-F | Putative avian hemolysin | GGTTGCCCGACCATCAATT | 60 | 61 | |
| hlyF-R | ACTGGTTGAAGGTAAGCACCCTAA | ||||
| FAM | TTGTTGGCCACAGTCG | ||||
| ompT-F | Episomal outer membrane protease gene | GGTTCCGGGATTGCTCGTAT | 60 | 57 | |
| ompT-R | GGTCGTGGAGGCAATATGGT | ||||
| VIC | CAGCCAGTCCCTGTC | ||||
| iroN-F | Salmochelin siderophore receptor gene | CCGTTGGTGCAGAGTGGAA | 60 | 53 | |
| iroN-R | CAGGCTGGTAGAGGAAGGATCA | ||||
| FAM | CGCGATAAGCTCG | ||||
| st×1-F | Shiga toxin 1 (st×1) | GCAAAGAMGTATGTWGATTCG | 55 | 107 | [ |
| st×1-R | GWGCCACTATCAATCATCAG | ||||
| ROX | TTCGCTCTGCAATAGGTACKCCAT | ||||
| st×2-F | Shiga toxin 2 (st×2) | AATGCAAATCAGTCGTCAC | 55 | 82 | |
| st×2-R | TGCATCTCTGGTCATTGTAT | ||||
| FAM | CACTGGTTTCATCATATCTGGCGTT | ||||
| eae-F | Intimin | GCTATAACRTCTTCATTGATC | 52 | 92 | |
| eae-R | RCTACTTTTRAAATAGTCTCG | ||||
| FAM | TTCGCCACCAATACCTAAACGG | ||||
| ehxA-F | Enterohaemolysin (ehxA) | GCACCACAACTTGAYAAACT | 55 | 86 | |
| ehxA-R | CCAGATTATTACCTACATTYTCAG | ||||
| FAM | TTTACTCCCAACGTTCTGATACTTCTG | ||||
| est-F | ST toxin (est) | TGAAAGCATGAATRGTAGCAA | 54 | 72 | |
| est-R | TTAATAACATSSAGCACAGG | ||||
| FAM | CAGGATTACAACAMARTTCACAGCAGT | ||||
| elt-F | LT toxin (elt) | GGYAAAAGAGAAATGGTTAT | 54 | 142 | |
| elt-R | TCTCGGTCAGATATGYGATTC | ||||
| ROX | TGTGTCCTTCATCCTTTCAATGGC | ||||
| bfpA-F | Bundle- forming pilus (bfpA) | CMGGTGTGATGTTTTACTAC | 53 | 109 | |
| bfpA-R | TGCCCAATATACARACCAT | ||||
| FAM | AGTCTGCGTCTGATTCCAATAAGKC | ||||
| invA-F | Invasion plasmid (spa24) | CCAATCACAATATCAGTACCA | 53 | 159 | |
| invA-R | AAAGAGCCTTATTACCCATAT | ||||
| ROX | AGACACATTACCTCCATCATCTAAGCA | ||||
| aggR-F | Enteroaggregative regulator (aggR) | TTTATCGCAATCAGATTAARC | 56 | 94 | |
| aggR-R | GGACAACTRCAAGCATCTAC | ||||
| ROX | ACATTAAGACGCCTAAAGGATGCC | ||||
| rfb O157-F | rbfO157 | CAAAAGGAAACTATATTCAGAAGT | 55 | 125 | |
| rfb O157-R | CGATATACCTAACGCTAACAA | ||||
| FAM | ATTCCTCTCTTTCCTCTGCGGTC | ||||
| wzx O104-F | wzxO104 | GCGCAAAGAATTTCAACTT | 55 | 99 | |
| wzx O104-R | TGTAAAATCCTTTAAACTATACG | ||||
| ROX | TGAAATGACACCACTTATTGCTAATACA |
Figure-1Distribution of Escherichia coli isolates (n=86) concerning the clinical status of the flocks and the site of sampling.
Figure-2Heat map representation of the antimicrobial-resistant profile of Escherichia coli isolates (n=86) recovered from healthy and diseased backyard chickens.
The MIC50, MIC90, and MIC range and resistance percentage of Escherichia coli (n=86) isolate from healthy and diseased birds.
| Antibiotic | No. | R% | MIC50 | MIC90 | MIC Range | No. of resistant | |||
|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
| Clinical status | Sample site | ||||||||
|
|
| ||||||||
| Normal Birds | Diseased Birds | Cloacal swabs | Internal organs | ||||||
| AMP | 65 | 75.6 | 64 | 128 | 1-164 | 10 (15.4) | 55 (84.6) | 43 (66.1) | 22 (33.9) |
| AMC | 11 | 12.8 | 4 | 32 | 1-64 | 0 (0.0) | 11 (100) | 10 (90.9) | 1 (9.1) |
| CTX | 8 | 9.3 | 0.5 | 1 | 0.125-16 | 0 (0.0) | 8 (100) | 8 (100) | 0 (0.0) |
| FOX | 8 | 9.3 | 4 | 8 | 0.5-64 | 0 (0.0) | 8 (100) | 8 (100) | 0 (0.0) |
| IPM | 0 | 0 | 0.25 | 1 | 0.125-1 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| GEN | 34 | 39.5 | 4 | 32 | 1-64 | 2 (5.9) | 32 (94.1) | 22 (64.7) | 12 (35.3) |
| CIP | 16 | 18.6 | 0.125 | 4 | 0.125-8 | 0 (0.0) | 16 (100) | 11 (68.8) | 5 (31.2) |
| SXT | 9 | 10.5 | 2 | 8 | 1-16 | 2 (22.2) | 7 (77.8) | 6 (66.7) | 3 (33.3) |
| AZM | 8 | 9.3 | 8 | 16 | 2-64 | 4 (50) | 4 (50) | 8 (100) | 0 (0.0) |
| TCY | 25 | 29.1 | 4 | 32 | 2-64 | 2 (8) | 23 (98) | 16 (64) | 9 (36) |
MDR=Multidrug resistance, AMP=Ampicillin, AMC=Amoxicillin-clavulanate, FOX=Cefoxitin, IPM=Imipenem, GEN=Gentamicin, MIC=Minimum inhibitory concentration, CTX=Cefotaxime, TCY=Tetracycline, SXT=Trimethoprim/sulfamethoxazole, AZM=Azithromycin
Figure-3Spearman rank correlation coefficient between the antimicrobials based on minimum inhibitory concentration of 86 Escherichia coli isolates.
Drug resistance profile and MDR index of Escherichia coli isolates (n=86).
| Resistance profile | Number of isolates (%) | MAR index |
|---|---|---|
| 21 (24.4) | 0 | |
| AMP | 7 (8.1) | 0.1 |
| AMP AZM | 8 (9.3) | 0.2 |
| AMP SXT | 6 (7) | 0.2 |
| AMP CIP | 6 (7) | 0.2 |
| AMP TCY | 4 (4.7) | 0.2 |
| AMP GEN | 4 (4.7) | 0.2 |
| AMP GEN CIP | 4 (4.7) | 0.3 |
| AMP GEN TCY | 6 (7) | 0.3 |
| AMP GEN TCY CIP | 6 (7) | 0.4 |
| AMP AMC GEN TCY | 6 (7) | 0.4 |
| AMP AMC FOX CTX GEN | 5 (5.8) | 0.5 |
| AMP FOX CTX GEN TCY SXT | 3 (3.5) | 0.6 |
MDR=Multidrug resistance, AMP=Ampicillin, AMC=Amoxicillin-clavulanate, FOX=Cefoxitin, IPM=Imipenem, GEN=Gentamicin, MAR=Multiple antibiotic resistance, CTX=Cefotaxime, TCY=Tetracycline, SXT=Trimethoprim/sulfamethoxazole, AZM=Azithromycin
Figure-4Biofilm formation: the mean OD of strong, moderate, weak, and negative biofilm producer Escherichia coli and the mean value of multidrug resistance index in each group.
Figure-5The distribution of the four biofilm formation groups among Escherichia coli strains isolated from healthy and diseased birds and the strains that exhibited multidrug resistance profile.
Figure-6Heat map representation of virulence gene profile of Escherichia coli isolates (n=86) recovered from healthy and diseased backyard chickens.
Virulence genes, biofilm formation, and MDR in different Escherichia coli pathotypes.
| Pathotype | NO | MDR | Biofilm | Virulence genes | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
| APEC | 28 | 9 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28 | 26 | 23 | 28 | 28 |
| EAEC | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| EHEC | 8 | 2 | 3 | 5 | 6 | 8 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPEC | 34 | 19 | 31 | 0 | 0 | 34 | 34 | 0 | 0 | 34 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| ETEC | 5 | 0 | 3 | 0 | 0 | 0 | 0 | 5 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Path | 10 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MDR=Multidrug resistance, EHEC=Enterohemorrhagic Escherichia coli, EPEC=Enteropathogenic Escherichia coli, ETEC=Enterotoxigenic Escherichia coli, APEC=Avian pathogenic Escherichia coli